CONCLUSION: the dosage of Herba Asari in ancient, modern and present times prescriptions is far away from the regulation dosage of pharmacopoeia.
结论：古、近代、现代临床处方中细辛用量与现行《药典》规定的用量相距甚远。
AIM: To investigate the reasonableness test of different parts of Herba Asari.
前言：目的：考察细辛不同部位应用的合理性。
METHODS:HPLC method was used to determine aristolochic acid A content content in different parts of Herba Asari.
方法：用高效液相测定细辛不同部位马兜铃酸A的含量。
The yield of crude polysaccharide from Herba Asari was 9.6%.
细辛全草粉碎后经沸水提取得到细辛粗多糖，总得率为9.6%。
CONCLUSION it is reasonable that the 2005 edition of Chinese Pharmacopoeia specifies that the medicinal part of Herba cum Radice Asari is...
结论2005年版的《中国药典》将细辛药用部位由全草改为根茎是合理的，穴贴定喘膏未检出马兜铃酸a。
CONCLUSION it is reasonable that the 2005 edition of Chinese Pharmacopoeia specifies that the medicinal part of Herba cum Radice Asari is...
结论2005年版的《中国药典》将细辛药用部位由全草改为根茎是合理的，穴贴定喘膏未检出马兜铃酸a。
应用推荐